Has Benjamin Young, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,082 in general payments to Benjamin Young, MD across 10 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Benjamin Young, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Benjamin Young, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Benjamin Young, MD

Retina Specialist · Portland, ORNPI 1447602362

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $669 of the $1,082 with a category attached, or 61.8%. Regeneron accounts for 67.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $790 and has fallen 91.6% since, to $66 in 2025. That places this record below the midpoint for retina specialist clinicians in OR, where the typical reported total is $1,870.

$1,082in general payments, 2019–2025

Across 10 payments — averaging $108.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Regeneron$734
Alcon$168
Glaukos Corporation$149
Johnson & Johnson Surgical Vision, Inc.$30

What the payments were for

Travel & lodging$66962%
Food & beverage$41338%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Regeneron	3	$734
Alcon	4	$168
Glaukos Corporation	2	$149
Johnson & Johnson Surgical Vision, Inc.	1	$30

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,082 in reported general payments places this provider in the 40th percentile of 36 retina specialist providers in Oregon.

See all retina specialist providers in Oregon →

Medicare billing

Part B allowed, 2024

$559,196

Medicare patients

320

Services billed

7,745

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	18	$10,377
Prednisolone Acetate	27	$1,255
Omeprazole	14	$505
Pravastatin Sodium	12	$481
Tamsulosin Hcl	16	$377
Finasteride	12	$335
Latanoprost	11	$199
Spironolactone	18	$172
Furosemide	12	$100
Losartan Potassium	15	$62

Paid to pharmacies, not to this prescriber.

Other retina specialist in Portland

Brian Chan KaiPortland$155K
Brandon LujanPortland$33K
Andreas LauerPortland$17K
Sirichai PasadhikaPortland$6K
David WilsonPortland$5K
Harpal SandhuPortland$3K
Aristomenis ThanosPortland$3K
Michael LeePortland$3K
Paul TlucekPortland$2K
Kavita BhavsarPortland$2K

See the full list for Oregon →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →